Role for the Rac1 exchange factor Vav in the signaling pathways leading to NK cell cytotoxicity

Journal of Immunology

Volumn 162, Issue 6, 1999, Pages 3148-3152

  Galandrini, Ricciarda ^a   Palmieri, Gabriella ^a,b   Piccoli, Mario ^a   Frati, Luigi ^a,d   Santoni, Angela ^a,c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Inst the Stud and Cure of Tumors   (Italy)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^d IRCCS NEUROMED   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; GENE PRODUCT; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG; VAV PROTEIN;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL INTERACTION; CELL LINE; CELL MEDIATED CYTOTOXICITY; DOWN REGULATION; HUMAN; HUMAN CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTO ONCOGENE; RECEPTOR BINDING; SIGNAL TRANSDUCTION; TARGET CELL;

ANIMALS; CELL CYCLE PROTEINS; CYTOTOXICITY TESTS, IMMUNOLOGIC; CYTOTOXICITY, IMMUNOLOGIC; GTP-BINDING PROTEINS; HUMANS; K562 CELLS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-VAV; RAC GTP-BINDING PROTEINS; RECEPTORS, IGG; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; TYROSINE;

EID: 0033559142     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Collins, T. L., M. Deckert, and A. Altman. 1997. Views on Vav. Immunol. Today 18:221.
2. Fischer, K.-D., Y.-Y. Kong, H. Nishina, K. Tedford, L. E. M. Marangère, I. Kozieradski, T. Sasaki, M. Starr, G. Chang, S. Gardener, et al. 1998. Vav is a regulator of cytoskeletal reorganization mediated by the T-cell receptor. Curr. Biol. 8:554.
3. Holsinger, L. J., I. A. Graef, W. Swat, T. Chi, D. M. Bautista, L. Davidson, R. S. Lewis, F. W. Alt, and G. R. Crabtree. 1998. Defect in actin-cap formation in Vav-deficient mice implicates an actin requirement for lymphocyte signal transduction. Curr. Biol. 8:563.
4. Crespo, P., K. E. Schuebel, A. A. Ostrom, J. S. Gutkind, and X. R. Bustelo. 1997. Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product. Nature 385:169.
5. Han, J., B. Das, W. We, L. Van Aelst, R. D. Mosteller, R. Khosravi-Far, J. K. Westwick, C. J. Der, and D. Broek. 1997. Lck regulates Vav activation of members of the Rho family GTPases. Mol. Cell. Biol. 17:1346.
6. Deckert, M., S. Tartare-Deckert, C. Couture, T. Mustelin, and A. Altman. 1996. Functional and physical interaction of syk family kinases with the vav proto-oncogene product. Immunity 5:591.
7. Bonnefoy-Berard, N., A. Munshi, I. Yron, S. Wu, T. L. Collinis, M. Deckert, T. Shalom-Barak, L. Giampa, E. Herbert, J. Hernandez, et al. 1996. Vav: function and regulation in hematopoietic cell signaling. Stem Cells 14:250.
8. Podack, E. R., and A. Kupfer. 1991. T-cell effector functions: mechanisms for delivery of cytotoxicity and help. Annu. Rev. Cell Biol. 7:479.
9. Carpen, O., I. Virtanen, V. P. Lehto, and E. Saksela. 1983. Polarization of NK cell cytoskeleton upon conjugation with sensitive target cells. J. Immunol. 131:2695.
10. Brumbaugh, K. M., B. A. Binstadt, D. D. Billadeau, R. A. Schoon, C. J. Dick, R. M. Ten, and P. J. Leibson. 1997. Functional role for Syk tyrosine kinase in natural killer cell-mediated natural cytotoxicity. J. Exp. Med. 186:1965.
11. ras activation is associated with Shc and p36 tyrosine phosphorylation and their binding with Grb2 in human natural killer cells. J. Exp. Med. 183:179.
12. Galandrini, R., R. De Maria, M. Piccoli, L. Frati, and A. Santoni. 1994. CD44 triggering enhances human NK cell cytotoxic function. J. Immunol. 153:4399.
13. Einspahr, K. J., R. T. Abraham, B. A. Binstadt, Y. Uehara, and P. J. Leibson. 1991. Tyrosine phosphorylation provides an early and requisite signal for the activation of natural killer cell cytotoxic function. Proc. Natl. Acad. Sci. USA 88:6279.
14. Teramoto, H., P. Salem, K. C. Robbins, X. R. Bustelo, and J. S. Gutkind. 1997. Tyrosine phosphorylation of the vav proto-oncogene product links Fc∈RI to the Racl-JNK pathway. J. Biol. Chem. 272:10751.
15. Leibson, P. J. 1997. Signal transduction during natural killer cell activation: inside the mind of a killer. Immunity 6:655.
16. Han, J., K. Luby-Phelps, B. Das, X. Shu, Y. Xia, R. D. Mosteller, U. Murali Krishna, J. R. Falck, M. A. White, and D. Broek. 1998. Role of substrates and product of Pl 3-kinase in regulating activation of rac-related guanosine triphosphatases by Vav. Science 279:558.
17. Bonnema, J. D., L. M. Karnitz, R. A. Schoon, R. T. Abraham, and P. J. Leibson. 1994. Fc receptor stimulation of phosphalidylinositol 3-kinase in natural killer cells is associated with protein kinase C-independent granule release and cell-mediated cytotoxicity. J. Exp. Med. 180:1427.
18. Cerione, R. A., and Y. Zheng. 1996. The Dbl family of oncogenes. Curr. Opin. Cell. Biol. 8:216.
19. Cox, D., P. Chang, Q. Zhang, P. G. Reddy, G. M. Bokoch, and S. Greenberg. 1997. Requirements for both rac1 and CDC42 in membrane ruffling and phagocytosis in leukocytes. J. Exp. Med 186:1487.
20. 52 Neisseria gonorrhoeae requires a Src-like tyrosine kinase- and rac1-dependent signaling pathway. EMBO J. 17:443.
21. Hartwing, J., G. M. Bokoch, C. L. Carpenter, P. A. Janmey, L. A. Taylor, A. Toker, and T. P. Stossel. 1995. Thrombin receptor ligation and activated rac uncap actin filament barbed ends through phosphoinositide synthesis in permeabilized human platelets. Cell 82:643.
22. Guillemot, J.-C., P. Montcourrier, E. Vivier, J. Davoust, and P. Chavrier. 1997. Selective control of membrane ruffling and actin plaque assembly by the rho GTPases rac1 and CDC42 in FceRI-activated rat basophilic leukemia (RBL-2H3) cells. J. Cell Sci. 110:2215.
23. Billadeau, D. D., K. M. Brumbaugh, C. J. Dick, R. A. Schoon, X. R. Bustelo, and P. J. Leibson. 1998. The Vav-Rac1 pathway in cytotoxic lymphocytes regulates the generation of cell-mediated killing. J. Exp. Med. 188:549.
24. Chong, L. D., A. Traynor-Kaplan, G. M. Bokoch, and M. A. Schwartz. 1994. The small GTP-binding protein Rho regulates phosphalidylinositol 4-phosphate 5-kinase in mammalian cells. Cell 79:507.
25. O'Rourke, L. M., R. Tooze, M. Turner, D. M. Sandoval, R. H. Carter, V. L. J. Tybulrwicz, and D. T. Fearon. 1998. CD19 as a membrane-anchored adaptor protein of B lymphocytes: costimulation of lipid and protein kinases by recruitment of vav. Immunity 8:635.